400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / TGF-beta/Smad / PKC / Delcasertib/KAI-9803游离态
CAS No.: 949100-39-4
Synonyms: KAI-9803;BMS-875944
KAI-9803 is a potent and selective δ protein kinase C (δ PKC) inhibitor.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00785954 | Myocardial Infarction ... more >> Cardiovascular Diseases Pathologic Processes Collapse << | Phase 2 | Completed | - | - |
NCT00093197 | Myocardial Infarction | Phase 1 Phase 2 | Completed | - | United States, North Carolina ... more >> Duke Clinical Research Institute Durham, North Carolina, United States, 27715 Collapse << |
实验方案
技术信息
CAS号 | 949100-39-4 | 储存条件 |
|
|
分子式 | C120H199N45O34S2 | 运输 | 蓝冰 | |
分子量 | 2880.28 | 别名 | KAI-9803;BMS-875944 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00785954 | Myocardial Infarction ... more >> Cardiovascular Diseases Pathologic Processes Collapse << | Phase 2 | Completed | - | - |
NCT00093197 | Myocardial Infarction | Phase 1 Phase 2 | Completed | - | United States, North Carolina ... more >> Duke Clinical Research Institute Durham, North Carolina, United States, 27715 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网